Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of “Hold” from Brokerages

Tempus AI, Inc. (NASDAQ:TEM) has been given an average rating of “Hold” by the seventeen brokerages that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, six have given a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $64.9231.

Several research firms recently issued reports on TEM. TD Cowen reiterated a “buy” rating on shares of Tempus AI in a report on Wednesday, July 15th. BTIG Research dropped their price objective on Tempus AI from $80.00 to $70.00 and set a “buy” rating for the company in a report on Monday. Needham & Company LLC restated a “buy” rating and set a $75.00 target price on shares of Tempus AI in a research report on Friday, July 31st. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tempus AI in a research note on Wednesday, June 17th. Finally, Lake Street Capital downgraded shares of Tempus AI to a “hold” rating in a research note on Monday, July 20th.

Insider Activity

In other news, CAO Ryan M. Bartolucci sold 4,116 shares of the firm’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $44.07, for a total value of $181,392.12. Following the transaction, the chief accounting officer directly owned 74,041 shares in the company, valued at $3,262,986.87. This trade represents a 5.27% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO James William Rogers sold 11,529 shares of Tempus AI stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $55.00, for a total value of $634,095.00. Following the sale, the chief financial officer directly owned 114,866 shares of the company’s stock, valued at approximately $6,317,630. This trade represents a 9.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 699,793 shares of company stock worth $33,763,231. Corporate insiders own 24.26% of the company’s stock.

Institutional Investors Weigh In On Tempus AI

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Victory Capital Management Inc. boosted its holdings in Tempus AI by 1.5% during the third quarter. Victory Capital Management Inc. now owns 11,078 shares of the company’s stock worth $894,000 after buying an additional 162 shares during the last quarter. Legacy Bridge LLC increased its stake in shares of Tempus AI by 1.6% in the 4th quarter. Legacy Bridge LLC now owns 12,418 shares of the company’s stock valued at $733,000 after acquiring an additional 193 shares during the last quarter. Truist Financial Corp increased its stake in shares of Tempus AI by 5.8% in the 4th quarter. Truist Financial Corp now owns 3,532 shares of the company’s stock valued at $209,000 after acquiring an additional 194 shares during the last quarter. Farther Finance Advisors LLC increased its stake in shares of Tempus AI by 3.5% in the 4th quarter. Farther Finance Advisors LLC now owns 6,390 shares of the company’s stock valued at $377,000 after acquiring an additional 219 shares during the last quarter. Finally, SeaCrest Wealth Management LLC raised its position in shares of Tempus AI by 3.7% in the 3rd quarter. SeaCrest Wealth Management LLC now owns 6,488 shares of the company’s stock valued at $524,000 after acquiring an additional 229 shares during the period. Institutional investors own 24.22% of the company’s stock.

Tempus AI Stock Up 2.2%

NASDAQ:TEM opened at $47.05 on Wednesday. The company has a market cap of $8.45 billion, a price-to-earnings ratio of -32.67 and a beta of 3.58. The company has a debt-to-equity ratio of 3.06, a quick ratio of 3.16 and a current ratio of 3.30. The stock’s fifty day moving average price is $51.41 and its two-hundred day moving average price is $52.28. Tempus AI has a 52-week low of $40.77 and a 52-week high of $104.32.

Tempus AI (NASDAQ:TEM) last released its earnings results on Thursday, July 30th. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.10. The company had revenue of $382.49 million during the quarter, compared to analysts’ expectations of $379.69 million. Tempus AI had a negative return on equity of 50.28% and a negative net margin of 17.77%.The business’s revenue for the quarter was up 21.6% on a year-over-year basis. During the same period last year, the firm earned ($0.22) EPS. On average, analysts anticipate that Tempus AI will post -1.35 EPS for the current year.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.